{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-001785","form_type":"8-K","ticker":"BBNX","cik":"0001674632","company_name":"Beta Bionics, Inc.","filed_at":"2025-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.400955+00:00","generated_at":"2026-05-24T03:56:44.310914+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Beta Bionics appoints Gerard Michel as Class III director","bullets":["Gerard Michel appointed to board effective March 26, 2025; term expires at 2028 annual meeting.","Michel currently CEO of Delcath Systems; former CFO of Vericel, Biodel, and NPS Pharmaceuticals.","Annual cash retainer of $50,000; initial RSU grant of 12,547 shares vesting on one-year anniversary.","No material arrangements or transactions with Michel requiring disclosure under Item 404(a)."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-001785","json":"https://secwatch.observer/filing/0001171843-25-001785.json","markdown":"https://secwatch.observer/filing/0001171843-25-001785.md","text":"https://secwatch.observer/filing/0001171843-25-001785.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674632/000117184325001785/0001171843-25-001785-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674632/000117184325001785/f8k_032725.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T03:56:44.310914+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ed0769b5ce","claim":"Gerard Michel was appointed as Class III director at Beta Bionics, Inc..","evidence_excerpt":"On March 26, 2025, the Board of Directors (the “Board”) of Beta Bionics, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Gerard Michel as a Class III director of the Company, with a term of office expiring at the 2028 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674632/000117184325001785/0001171843-25-001785-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}